Ilkka Julkunen - UTU Research Portal

Ilkka Julkunen

- ,
InFLAMES Flagship (Faculty of Medicine)
- Senior Advisor,
Institute of Biomedicine (Faculty of Medicine)

ilkka.julkunen@utu.fi

+358 29 450 4507

+358 50 449 9721

Kiinamyllynkatu 10

Turku

6 of 6

Mutations within the conserved NS1 nuclear export signal lead to inhibition of influenza A virus replication. (2014)
- Virology Journal
Janne Tynell, Krister Melén, Ilkka Julkunen
Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination (2014)
- Lancet Neurology
Markku Partinen, Birgitte Rahbek Kornum, Giuseppe Plazzi, Poul Jennum, Ilkka Julkunen, Outi Vaarala
Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. (2014)
- Proceedings of the National Academy of Sciences of the United States of America
Peter Bergman, Csaba Adori, Szilvia Vas, Ylva Kai-Larsen, Tomi Sarkanen, Andreas Cederlund, Birgitta Agerberth, Ilkka Julkunen, Beata Horvath, Diana Kostyalik, Lajos Kalmár, Gyorgy Bagdy, Anne Huutoniemi, Markku Partinen, Tomas Hökfel
Novel avian influenza A (H7N9) virus induces impaired interferon responses in human dendritic cells (2014)
- PLoS ONE
Veera Arilahti, Sanna M. Mäkelä, Janne Tynell, Ilkka Julkunen, Pamela Österlund
Sinun influenssarokotuksesi on osa potilasturvallisuutta (2014)
- Lääkärilehti
Ilkka Julkunen, Anu Haveri, Carita Savolainen-Kopra, Outi Lyytikäinen, Eeva Ruotsalainen, Anu Kantele, Veli-Jukka Anttila, Hanna Nohynek
Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals (2013)
- Influenza and Other Respiratory Viruses
Strengell M, Ikonen N, Ziegler T, Kantele A, Anttila VJ, Julkunen I
Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice (2013)
- Cell Death and Disease
Kakkola L, Denisova OV, Tynell J, Viiliainen J, Ysenbaert T, Matos RC, Nagaraj A, Ohman T, Kuivanen S, Paavilainen H, Feng L, Yadav B, Julkunen I, Vapalahti O, Hukkanen V, Stenman J, Aittokallio T, Verschuren EW, Ojala PM, Nyman T, Saelens X, Dzeyk K, Kainov DE
Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. (2013)
- Influenza and Other Respiratory Viruses
Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW, H1N1pdm serology working group (incl. Julkunen I)
Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions. (2013)
- Journal of Medical Virology
Kaukinen P, Sillanpää M, Nousiainen L, Melén K, Julkunen I
Human kinome analysis reveals novel kinases contributing to virus infection and retinoic-acid inducible gene I-induced type I and type III IFN gene expression. (2013)
- Innate Immunity
Nousiainen L, Sillanpää M, Jiang M, Thompson J, Taipale J, Julkunen I
Jälleen uusi lintuinfluenssa – onko syytä huolestua? (2013)
- Lääkärilehti
Julkunen I, Österlund P
MERS – uusi vakavia hengitystieinfektioita aiheuttava koronavirus (2013)
- Lääkärilehti
Julkunen I, Tynell J, Ikonen N
No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix Vaccination Campaign in Finland (2013)
- PLoS ONE
Melén K, Partinen M, Tynell J, Sillanpää M, Himanen SL, Saarenpää-Heikkilä O, Hublin C, Olsen P, Ilonen J, Nohynek H, Syrjänen R, Kilpi T, Vuorela A, Kirjavainen T, Vaarala O, Julkunen I